• LAST PRICE
    57.4200
  • TODAY'S CHANGE (%)
    Trending Down-0.1100 (-0.1912%)
  • Bid / Lots
    57.3900/ 3
  • Ask / Lots
    57.4500/ 4
  • Open / Previous Close
    57.0300 / 57.5300
  • Day Range
    Low 56.8500
    High 58.4899
  • 52 Week Range
    Low 56.8500
    High 100.7700
  • Volume
    496,758
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 57.53
TimeVolumeEXAS
09:32 ET4609157.28
09:33 ET329557.4
09:35 ET530757.57
09:37 ET666957.8056
09:39 ET344657.895
09:42 ET1426557.745
09:44 ET741857.95
09:46 ET692757.98
09:48 ET245057.825
09:50 ET528658.06
09:51 ET396558.1392
09:53 ET497658.145
09:55 ET907458.17
09:57 ET329858.27
10:00 ET355758.345
10:02 ET709158.33
10:04 ET545058.26
10:06 ET460258.32
10:08 ET1692958.33
10:09 ET265558.26
10:11 ET392958.165
10:13 ET529157.965
10:15 ET559257.9
10:18 ET563657.81
10:20 ET250057.58
10:22 ET358757.59
10:24 ET513157.53
10:26 ET744257.51
10:27 ET625157.405
10:29 ET650257.65
10:31 ET510657.545
10:33 ET523757.67
10:36 ET386557.55
10:38 ET665557.554
10:40 ET545257.57
10:42 ET536957.62
10:44 ET232257.565
10:45 ET581457.58
10:47 ET592657.55
10:49 ET499757.56
10:51 ET417757.645
10:54 ET605157.57
10:56 ET592857.49
10:58 ET493457.535
11:00 ET555557.46
11:02 ET1533257.34
11:03 ET1046957.31
11:05 ET968257.395
11:07 ET1055557.345
11:09 ET800757.34
11:12 ET724757.39
11:14 ET411057.42
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEXAS
Exact Sciences Corp
10.4B
-50.6x
---
United StatesUTHR
United Therapeutics Corp
10.7B
11.3x
+8.22%
United StatesQGEN
Qiagen NV
9.7B
28.5x
+12.66%
United StatesMEDP
Medpace Holdings Inc
12.4B
45.4x
+35.10%
United StatesNBIX
Neurocrine Biosciences Inc
13.4B
54.9x
+62.04%
United StatesBMRN
Biomarin Pharmaceutical Inc
17.2B
103.1x
---
As of 2024-02-26

Company Information

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test and COVID-19 Testing. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Contact Information

Headquarters
5505 Endeavor LaneMADISON, WI, United States 53719
Phone
608-284-5700
Fax
608-284-5701

Executives

Chairman of the Board, President, Chief Executive Officer
Kevin Conroy
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Jeffrey Elliott
Executive Vice President - Human Resources
Sarah Condella
Senior Vice President, General Counsel, Company Secretary
James Herriott
General Manager - Precision Oncology
Brian Baranick

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.4B
Revenue (TTM)
$2.5B
Shares Outstanding
180.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.23
EPS
$-1.14
Book Value
$17.34
P/E Ratio
-50.6x
Price/Sales (TTM)
4.2
Price/Cash Flow (TTM)
4,166.7x
Operating Margin
-8.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.